Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evolent Health, Inc. Director's Dealing 2021

Dec 17, 2021

32214_dirs_2021-12-17_b762b295-ee65-45a0-aa34-b81553767548.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-12-17

Reporting Person: WILLIAMS FRANK J (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-17 Class A Common Stock M 10000 $3.84 Acquired 597809 Direct
2021-12-17 Class A Common Stock S 10000 $26.64 Disposed 587809 Direct
2021-12-17 Class A Common Stock S 10000 $26.65 Disposed 577809 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-17 Class A Common Stock Option (right to buy) $3.84 M 10000 Disposed 2024-04-01 Class A Common Stock (10000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 66064 Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2021.

F2: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.22 to $27.04, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $27.07, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.

F6: The Class A Common Stock Options exercised vested on December 1, 2014.